ATLASOrganon & Co. (OGN) earnings date: Nov 9, 2026
Organon & Co. (OGN) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026. Analysts expect EPS of $0.95.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on OGN
| Last price | $13.83 (-0.1%) |
|---|---|
| Normal 1-day range (±1σ) | ±1.2% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 5 reports |
| Dividend | $0.08 a year (0.58% yield) |
These figures come from the same calibrated model and valuation as the Organon & Co. stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Organon & Co. reports on Nov 9, 2026. One email the day before, with ATLAS’s read on Organon & Co.. You can switch it off at any time.
Alert me before OGN reportsFree to start. Creating an account takes under a minute.
Notify me when Organon & Co. reports
Track OGN free Add Organon & Co. to a free ATLAS watchlist and see its next report date in one place.
OGN earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $0.95 |
| Last report | Jul 31, 2026 · Miss |
| Beat rate (last 5 reports) | 1 of 5 (20%) |
| Average EPS surprise | +3.2% |
| Average move around a report | ±2.7% (last 5) |
| Sector | Healthcare · Drug Manufacturers - General |
Organon & Co. earnings history: last 5 reports
Organon & Co. last reported on Jul 31, 2026: EPS of $0.85 against an estimate of $1.07 (-20.6% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 31, 2026 | $1.07 | $0.85 | -20.6% | Miss | +0.1% |
| Apr 30, 2026 | $0.85 | $0.71 | -16.5% | Miss | -0.4% |
| Feb 12, 2026 | $0.73 | $0.63 | -13.7% | Miss | -3.9% |
| Jan 28, 2026 | $1.03 | $1.03 | 0.0% | In line | -4.4% |
| Dec 3, 2025 | $0.27 | $0.45 | +66.7% | Beat | -4.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for OGN
See the fair value, the probability range and the earnings history of Organon & Co. on its ATLAS page.
Organon & Co. (OGN) stock analysisPlans from €3.99 a month.
Organon & Co. earnings: frequently asked questions
When does Organon & Co. (OGN) report earnings?
Organon & Co. is scheduled to report on Monday, November 9, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for OGN?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $0.95 per share (USD). Estimates can change before the report.
How often does OGN beat earnings estimates?
Of its last 5 reports with a recorded result, Organon & Co. beat the EPS estimate 1 times; the average surprise was +3.2%. Past results do not predict the next one.
How much does OGN move around earnings?
Over its last 5 reports the stock moved an average of 2.7% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Organon & Co. beat earnings estimates last quarter?
Organon & Co. last reported on Jul 31, 2026: EPS of $0.85 against an estimate of $1.07 (-20.6% surprise), a miss.
How much does OGN usually move in a day?
On a normal trading day the ATLAS model puts OGN’s one-day range at about ±1.2%, with a 51% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer